TDS Pharm Co (XKRX:464280) 3-Year EBITDA Growth Rate : -70.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co 3-Year EBITDA Growth Rate?

TDS Pharm Co's EBITDA per Share for the three months ended in Dec. 2024 was ₩129.45.

During the past 12 months, TDS Pharm Co's average EBITDA Per Share Growth Rate was -30.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -70.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of TDS Pharm Co was -62.40% per year. The lowest was -70.00% per year. And the median was -66.20% per year.

Competitive Comparison of TDS Pharm Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, TDS Pharm Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TDS Pharm Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where TDS Pharm Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

TDS Pharm Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

TDS Pharm Co (XKRX:464280) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

TDS Pharm Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines